Champions Oncology, Inc. Q1 FY2025 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2025 Q1 Call date: 2024-09-11 Concluded

Quarter scorecard

Revenue

$14.06M

+11.9% YoY

Diluted EPS

$0.09

Net income

$1.31M

Pharmacology Services $13.07M

+10.2%

Product And Service Other $992,000

+45%

Translational Oncology Solutions TOS License Revenue $0